These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23526261)

  • 1. Should we abandon statins in the prevention of bone fractures?
    Esposito K; Capuano A; Sportiello L; Giustina A; Giugliano D
    Endocrine; 2013 Oct; 44(2):326-33. PubMed ID: 23526261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxymethylglutaryl-coenzyme A reductase inhibitors in osteoporosis management.
    Coons JC
    Ann Pharmacother; 2002 Feb; 36(2):326-30. PubMed ID: 11847956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?
    Schlienger RG; Meier CR
    Drugs Aging; 2003; 20(5):321-36. PubMed ID: 12696993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.
    Hatzigeorgiou C; Jackson JL
    Osteoporos Int; 2005 Aug; 16(8):990-8. PubMed ID: 15744453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study.
    LaCroix AZ; Cauley JA; Pettinger M; Hsia J; Bauer DC; McGowan J; Chen Z; Lewis CE; McNeeley SG; Passaro MD; Jackson RD
    Ann Intern Med; 2003 Jul; 139(2):97-104. PubMed ID: 12859159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and bone metabolism.
    Horiuchi N; Maeda T
    Oral Dis; 2006 Mar; 12(2):85-101. PubMed ID: 16476028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women.
    Chan KA; Andrade SE; Boles M; Buist DS; Chase GA; Donahue JG; Goodman MJ; Gurwitz JH; LaCroix AZ; Platt R
    Lancet; 2000 Jun; 355(9222):2185-8. PubMed ID: 10881890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins and fracture risk. A systematic review.
    Toh S; Hernández-Díaz S
    Pharmacoepidemiol Drug Saf; 2007 Jun; 16(6):627-40. PubMed ID: 17286319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of statins for osteoporosis: a systematic review and meta-analysis.
    An T; Hao J; Sun S; Li R; Yang M; Cheng G; Zou M
    Osteoporos Int; 2017 Jan; 28(1):47-57. PubMed ID: 27888285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG CoA reductase inhibitors and the skeleton: a comprehensive review.
    Bauer DC
    Osteoporos Int; 2003 Jun; 14(4):273-82. PubMed ID: 12736772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal effects of statins.
    Yaturu S
    Endocr Pract; 2003; 9(4):315-20. PubMed ID: 14561578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials.
    Yue J; Zhang X; Dong B; Yang M
    Menopause; 2010; 17(5):1071-9. PubMed ID: 20473231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins, fracture risk, and bone remodeling: What is true?
    Rizzo M; Rini GB
    Am J Med Sci; 2006 Aug; 332(2):55-60. PubMed ID: 16909050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and osteoporosis: a clinical review.
    Gonyeau MJ
    Pharmacotherapy; 2005 Feb; 25(2):228-43. PubMed ID: 15767237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and osteoporosis: can these lipid-lowering drugs also bolster bones?
    Cruz AC; Gruber BL
    Cleve Clin J Med; 2002 Apr; 69(4):277-8, 280-2, 287-8. PubMed ID: 11996199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anabolic effects of statin and beta-blocker on bone metabolism].
    Taguchi M; Takeuchi Y
    Clin Calcium; 2004 Dec; 14(12):89-94. PubMed ID: 15577180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.
    Bauer DC; Mundy GR; Jamal SA; Black DM; Cauley JA; Ensrud KE; van der Klift M; Pols HA
    Arch Intern Med; 2004 Jan; 164(2):146-52. PubMed ID: 14744837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential use of HMG-CoA reductase inhibitors for osteoporosis.
    Cushenberry LM; de Bittner MR
    Ann Pharmacother; 2002 Apr; 36(4):671-8. PubMed ID: 11918519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Are statins of value in therapy of osteoporosis?].
    Gosch M
    Wien Med Wochenschr; 2003; 153(11-12):255-7. PubMed ID: 12879634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.